Abbreviations: BBM, brush-border membrane; GLP-1, glucagon-like peptide 1; GLUT2, facilitative glucose transporter 2; HC, high carbohydrate; Hsp70, heat shock protein 70; LC, low carbohydrate; PKC, protein kinase C; RA, rosmarinic acid; SFT, Salvia fruticosa tea; SGLT1, Na(+)-glucose cotransporter 1; STZ, streptozotocin; T2DM, type 2 diabetes mellitus. on the levels and localization of the intestinal Na+/glucose cotransporter-1 (SGLT1), 5 the facilitative glucose transporter 2 (GLUT2) and glucagon-like peptide-1 (GLP-1). 6
Introduction

26
Diabetes mellitus affects 10 to 20% of adults worldwide and is characterized by 27 high levels of glucose in the blood. Particularly type 2 diabetes mellitus (T2DM), that 28 corresponds to 90 to 95% of all cases of diabetes, is attaining epidemic proportions in 29 populations with western-type diets and lifestyles [1] , in part due to loss of traditional 30 cooking with local ingredients, including herbs and spices. This justifies the search for 31 new active principles and therapeutical targets that help prevent and limit the 32 progression of this disease. Plants with antidiabetic reputation may be good sources of 33 compounds with these properties. 34 Herbs, such as ginseng (Panax spp.), fenugreek (Trigonella foenum graecum) 35 and bitter melon (Momordica charantia) and spices, such as cinnamon (Cinnamomum 36 zeylanicum), are examples of plants where antidiabetic properties have been identified 37 in experimental animals and clinical trials with T2DM patients [2] [3] [4] [5] . Salvia species, 38 such as Salvia officinalis and Salvia fruticosa, have also been used for their antidiabetic 39
properties [6, 7] . Because these plants are edible and palatable, they produce their 40 effects by inclusion in the diet. However, active principles and mechanisms of action 41 have not been elucidated. 42 Glucose released upon carbohydrate digestion is absorbed mainly in the jejunum 43 of the small intestine. The Na (+)-glucose cotransporter (SGLT1), localized to the 44 enterocyte apical or brush-border membrane (BBM), and the basolateral facilitative 45 glucose transporter 2 (GLUT2) are the main intestinal sugar transporters responsible for 46 glucose uptake from the intestinal lumen into the blood [8] . The Na + gradient necessary 47 for SGLT1 activity is maintained by the basolateral Na + /K + -ATPase. 48
The intestine has the ability to adapt functionally as well as morphologically to 49 stimuli such as diet composition and disease processes, such as diabetes [9] . Induction 50 7 after washing with PBS pH 7.4 (containing 40mM PMSF in ethanol added fresh). The 126 intestinal mucosa was immediately frozen in liquid nitrogen and stored at -80ºC until 127 use. Prior to scraping a small piece of intact jejunum (from the middle of the above 128 40cm region) was collected as well as pancreatic tissue for fixation in 4% 129 paraformaldehyde in PBS pH 7.4, for 24 h at 4ºC. The tissues were then stored in 130 ethanol 70% (v/v) until being processed for paraffin embedding. Blood samples were 131 also collected to measure glucose and insulin levels, as well as the activity of liver 132 transaminases. 133
An additional model of SGLT1 induction in intestinal mucosa through dietary 134
carbohydrate manipulation was used. For that, thirty rats were used and divided into 135 five groups of six animals each, where ( Fig. 1B) : group 1 -rats were fed with water and 136 food (normal rat chow -referred as high carbohydrate diet -HC) ad libitum for 14 137 days; group 2 -rats were fed with water and food (HC) ad libitum for 7 days, and 138 afterwards fed for 7 days with a soybean diet (low carbohydrate diet -LC) replacing the 139 normal rat chow ad libitum; group 3 -rats were treated as in group 2, and afterwards 140 fed for 4 days more with water and HC diet ad libitum; group 4 -rats were treated as in 141 group 2, and afterwards fed for 4 days more with daily fresh S. fruticosa tea (replacing 142 the water drinking) and HC diet ad libitum; group 5 -rats were treated as in group 4, 143 with daily fresh RA solution replacing the S. fruticosa tea drinking. The RA solution 144 was prepared in tap water diluting RA (Sigma-Aldrich) to the same concentration found 145 in the SFT (577μg/ml). 146
The composition of the food given to the rats are presented in Supporting 147
Information 
Isolation of Brush-Border Membranes 157
Brush-Border Membranes (BBM) were isolated from frozen jejunal mucosal scrapings 158 using a combination of cation precipitation and differential centrifugation as described 159
previously [18] with few modifications (for details, see Supporting Information 160
Materials and methods). BBM were then frozen in liquid nitrogen and stored at -80ºC 161 until use. The enrichment of the brush-border marker (by measuring the activity of 162 alkaline phosphatase [19] ) was about 10 times the mucosa crude homogenate. Protein 163 content was measured with the Bradford Reagent (Sigma-Aldrich) using BSA as a 164 standard. 165 166
Western blotting 167
The levels of SGLT1, GLUT2 and Hsp70 in the BBM was quantified by Western 168 blotting as described previously [20, 21] . BBM protein were solubilized in Laemmli's 169 buffer [22] and heated for 15 min at 70ºC. Then, 25µg of protein were loaded in each 170 well and separated by SDS-PAGE and transferred onto Hybond-P polyvinylidene 171 difluoride membrane (GE Healthcare, Buckinghamshire, UK). Membranes were 172 blocked in 5% (w/v) non-fat dry milk in TPBS (0.05% (v/v) Tween 20 in PBS) pH 7.4, 173 for 1 h, at room temperature and then incubated with rabbit antibody to rat SGLT1 174 (raised in rabbits against a peptide comprising amino acids 582-600:9 EEDPKDTIEIDAEAPQKEK of rat SGLT1 [23] ) or rabbit polyclonal to SGLT1 176 (Abcam, Cambridge, UK) diluted 1:500 or 1:2,000, respectively, overnight at 4ºC. After 177 secondary antibody incubation, immunoreactive bands were detected by 178 chemiluminescence exposing to a film. Membranes were also probed against GLUT2 179 (using rabbit polyclonal antibody from Chemicon International, Temecula, CA, USA) 180
and Hsp70 (using a mouse monoclonal antibody from Sigma-Aldrich). 181
The same procedure was used to quantify the abundance of SGLT1, GLUT2, Hsp70, 182 Na + /K + -ATPase (using α5 mouse monoclonal antibody [24] ) and PKC (using a rabbit 183 
Liver glycogen content 210
Liver glycogen content was quantified with amyloglucosidase as previously described 211 [25] . Dilutions of the liver homogenate were used to ensure that the determination was 212 done within the linear phase. The glycogen content was expressed in μmol glucose per g 213 of liver. 214 215
Statistical Analysis 216 Data are expressed as means with standard errors of the means (SEM). 217
For statistical analysis a two-way ANOVA was employed followed by the Newman-218 has no effects on plasma insulin and liver glycogen content 231
As expected, one week after the i.p. injection of STZ, fasting blood glucose increased 232 from about 119 ± 4 mg/dl in healthy rats to 311 ± 25 mg/dl in STZ-induced diabetic 233 animals ( Fig. 2A ). Plasma insulin concentration was significantly lower in diabetic 234 versus non-diabetic animals ( Fig. 2B) . In water drinking STZ-diabetic animals plasma 235 glucose levels continued to increase throughout the 14 day experimental period but 236 remained stable in SFT drinking STZ-diabetic animals ( Fig. 2A) . On day fourteen, SFT-237 treated diabetic animals showed significantly lower blood glucose levels than water 238 drinking controls ( Fig. 2A) . In non-diabetic (healthy) animals, fasting glucose levels 239 remained constant and were not affected by SFT drinking. 240 SFT drinking did not significantly changed liver glycogen content (Fig. 2C) or induced 241 liver toxicity (monitored by plasma transaminase levels -(Supporting Information 242 Table 2 ) or increased regeneration of beta-cell mass (Supporting Information Fig. 1) . 243 244
SFT treatment decreases enterocyte BBM SGLT1 in diabetic animals but has 245
no effects on healthy animals 246
As shown in Fig. 3 , STZ-diabetic rats showed a significant increase in SGLT1 levels 247 both in whole cell homogenates (40%) and in BBM (85%), when compared with 248 controls. Treatment with SFT for 14 days did not change SGLT1 levels in whole cell 249 homogenates (Fig. 3A) , but limited the increase in BBM to about 30% of levels in 250 12 untreated controls (Fig. 3B) . In healthy animals sage tea drinking did not change 251 SGLT1 levels. 252
In addition to its presence on the basolateral membrane, GLUT2, alongside SGLT1, 253 may play a role in intestinal glucose absorption at the BBM [11, 12, 26] , where its 254 abundance has been shown to increase with diabetes induction [26] . The levels of 255 GLUT2 were significantly increased in whole cell homogenates of jejunal mucosa of 256 STZ-diabetic rats when compared with healthy controls (Fig. 4A) but not in BBM 257 (Supporting Information Fig. 2) . Levels of Na + /K + -ATPase were higher in diabetic 258 animals ( As shown in Fig. 5 , feeding the LC diet for 7 days (HC-LC group) produced a 266 significant 15% reduction in plasma glucose levels (in fed animals), when compared 267 with HC-HC group. Four days after the reintroduction of the HC diet (HC-LC-HC 268 group), plasma glucose returned to control levels. However, in the RA group, the return 269 of plasma glucose to control levels was completely inhibited (Fig. 5) . 270 carbohydrate diet (HC) to animals where enterocyte BBM and total SGLT1 levels had 277 been dramatically reduced (by feeding a low carbohydrate (LC) diet for 7 days) resulted 278 in complete recovery of SGLT1 levels (Fig. 6 ). Replacing water with SFT or RA upon 279 reintroduction of the HC diet caused a significant inhibition of the adaptive increase of 280 SGLT1 levels in BBM of about 32% and 50%, respectively (Fig. 6B) , without affecting 281 total levels (Fig. 6A) . 282 283 3.5 SFT and rosmarinic acid decrease BBM Hsp70 and PKC levels 284
As shown in Fig. 7 , the levels of the constitutive form of Hsp70 in BBM, which 285 corresponds to only a small part of total Hsp70 (Fig. 7C) , decreased significantly in LC 286 fed animals, but returned to normal levels 4 days after the reintroduction of HC diet. 287 SFT and RA treatments inhibited this recovery, the effect being significant for RA. The 288 levels of Hsp70 in whole cell homogenates were not changed among the different 289 groups (Supporting Information Fig. 5 ). PKC levels (Fig. 8) were not affected by diet, 290 but were significantly lower in RA-treated animals. 291 292
Discussion 293
Control over carbohydrate digestion and absorption is beneficial in the 294 management of diabetes since it helps contain postprandial hyperglycemia excursions 295 thereby improving glycemic control and reducing the risk of diabetic complications 296 [27] . Many studies have reported that diabetes enhances intestinal glucose absorption, 297 although the mechanisms that underlie this effect are poorly understood. Higher levels 298 of intestinal BBM glucose transporters in both diabetic patients and experimental 299 diabetic animals [11, 12, 26, 28] , contributes significantly to the increased glucose 300 14 absorption in diabetes. However, there are, to our knowledge, no therapeutic attempts to 301 limit it. Inhibitors of SGLT1, such as phloridzin, have been known, although its 302 degradation by intestinal lactase-phloridzin hydrolase has been pointed out to limit its 303 pharmacological value. Inhibition of SGLT1 activity by other natural compounds, such 304 as tea polyphenols (e.g. epigallocatechin gallate) has also been shown [29] . However, 305 few studies show effects on SGLT1 levels in the BBM, where it is functionally active. 306
Recently, Gum Arabic has been shown to produce this effect [30] . Also, Miró-Queralt 307 et al. [31] also reported that sodium tungstate normalized SGLT1 expression in the 308 jejunum of STZ-diabetic rats. 309
Fourteen days of treatment with SFT presented no toxicity (plasma 310 transaminases not changed) and prevented further deterioration of glucose homeostasis 311 in STZ diabetic rats without affecting plasma insulin levels or liver glycogen deposition. 312
In a previous report [6] , SF water extracts was shown to decrease plasma glucose after 313 an oral glucose tolerance test but not an intravenous glucose tolerance test, suggesting 314 SFT acts at the intestinal level rather than by improving peripheral insulin sensitivity. 315
Because the intestinal effects are not due to digestive enzyme inhibition 316 (unpublished observations), in the present study, we hypothesized that SFT would exert 317 control over blood glucose through modulation of enterocyte glucose transporter levels. 318
To test this, two models of SGLT1 induction in rats were used: diabetes induction with 319 STZ and dietary carbohydrate manipulation. 320
As expected, three weeks after STZ administration to rats plasma glucose was 321 elevated, plasma insulin decreased, and enterocyte total and BBM levels of SGLT1 322 were increased, associated with diabetes induction. SFT drinking for 14 days in diabetic 323 animals significantly decreased SGLT1 levels at the BBM but not in mucosa whole cell 324
homogenates. This suggests effects of SFT on SGLT1 trafficking but not on total 325 15 protein levels. Because SFT reduced BBM SGLT1 levels in diabetic animals but had no 326 effects in healthy controls, this plant extract seems to act only when the mechanisms of 327 induction of BBM expression of intestinal glucose transporters are activated and does 328 not affect basal expression levels. 329
To confirm the effect of SFT on the regulation of SGLT1 BBM levels, a model 330 of its induced expression by dietary carbohydrate manipulation was used. As in the 331 diabetic animals, SFT treatment significantly inhibited the increase of SGLT1 levels in 332 the BBM after HC reintroduction, but not in whole cell homogenates. In an attempt to 333 identify the active principle present in SFT, its main phenolic compound -RA -was 334 used and shown to have an even stronger effect than the plant extract. The lower 335 expression of SGLT1 in the BBM of RA-treated group was associated with a significant 336 decrease of non-fasting plasma glucose levels measured in this group. 337
Our results indicate that SFT, and RA in particular, control the transporter levels 338 at the BBM by decreasing it in conditions where it is enhanced, such as in diabetes and 339 during adaptation to increased digestible carbohydrate in the diet. These effects on the 340 trafficking of SGLT1 at intestinal level, are paralleled by decreases in blood glucose and 341 identified RA as an active principle 342
There were no SFT effects on GLUT2 levels (total or BBM) that were only 343 slightly increased (not in BBM) in diabetic animals. Intestinal BBM GLUT2 has been 344 reported to be elevated in insulin resistant diabetic animals where the levels are not 345 reduced by insulin treatment [28] , contrary to levels of BBM SGLT1 that decrease upon 346 insulin administration [32] . 347
In agreement with previous reports [33] , the intestinal level of Na + /K + -ATPase 348 increased in association with diabetes. SFT treatment did not normalize these levels. 349
Effects on the incretin hormone GLP-1 would also be important components of any 350 intestinal effects of SFT. The incretin hormone GLP-1 potentiates the glucose-induced 351 insulin secretion by the beta-cells where it also has trophic effects [34, 35] , and inhibits 352 glucagon secretion, which justifies its clinical importance in the treatment of diabetes 353 [36] . The number of GLP-1 expressing cells per cm of villus in diabetic animals was, 354 however, not changed by SFT treatment. 355
The high antioxidant content of the sage extract [15] may contribute for the 356 protection/regeneration of insulin-producing beta-cells. Antioxidants reduce oxidative 357 stress and decrease glucotoxicity in pancreatic beta-cells, which have low antioxidant 358 defenses [37] . There were, however, no changes in pancreatic beta-cell mass in diabetic 359 animals after introduction of SFT treatment indicating no increased regeneration of the 360 insulin producing cells by SFT. 361
In order to shed light on the mechanisms of S. fruticosa and RA on translocation 362 to the BBM of SGLT1, heat shock protein 70 (Hsp70) and protein kinase C (PKC) were 363 quantified. Hsp70 has been reported to increase both translocation of SGLT1 to the 364 BBM and transport activity, through the formation of Hsp70/SGLT1 complexes [38, 365 39] . Our results show that Hsp70 levels profile in BBM was similar to that of SGLT1. 366
This indicates that SGLT1 translocation and stabilization to the BBM may, in fact, be 367 involved in the observed SFT effects. 368 PKC is implicated in the regulation of vesicle translocation containing glucose 369 transporters such as GLUT4 and GLUT2 [40] [41] [42] . It is well established that insulin leads 370 to the activation of atypical PKC and/or Akt (PKB), which results in the translocation of 371 GLUT4 from intracellular pools to the plasma membrane of myocytes or adipocytes 372 [41] . SGLT1 transporters reside also intracellularly in microtubule-associated vesicular 373 structures, and respond to mechanisms of vesicle trafficking [43] . However, insulin 374 signaling seems to have opposite effects in SGLT1 trafficking, since diabetic rats 375 treated with subcutaneous insulin significantly decreased BBM SGLT1 levels without 376 changes in mRNA [32] . Our results show that although sage tea only slightly affected 377 PKC levels in enterocytes, RA significantly decreased its expression. RA by decreasing 378 PKC levels may be contributing to retain SGLT1 in intracellular stores. However, 379 further research is needed to clarify the molecular mechanism(s) behind S. fruticosa and 380 RA effects on SGLT1 levels in BBM, and the involvement and relationship of both 381
Hsp70 and PKC in this process. 382
In conclusion, this study showed the ability of S. fruticosa to inhibit the adaptive 383 increase of SGLT1 levels in BBM of rat enterocytes both after induction by STZ 384 treatment and as a result of stimulation with HC diet. This effect appears to be due to 385 modulation of SGLT1 trafficking by SFT, where RA seems to be the active principle. 386
These data support previous reports on the antidiabetic effects of S. fruticosa, and 387 emphasize the importance of the small intestine, and in particular the manipulation of 388 BBM levels of SGLT1, in the therapeutic regulation of glucose homeostasis in diabetes. 389
390
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